EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses

Kefan Song iD, Dinh Chuong Nguyen iD, Yonghui Wang, Simbarashe Jokonya iD, Omeed Yazdani, Drew L Sellers iD, Patrick S Stayton, Suzie H Pun iD

Proceedings of the National Academy of Sciences · 11.11.2025 · 122 (45)

DOI: 10.1073/pnas.2409978122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.11.2025. Verfasst von Kefan Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Washington, Seattle, WA 98195. Hauptthemen laut MEDLINE: Cancer Vaccines, Membrane Proteins, Vaccines, Subunit. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptide therapeutic cancer vaccines are an attractive treatment modality for their safety and manufacturability but have been hindered in clinical translation by low immunogenicity and insufficient CD8 + T cell activation. We developed virus-inspired polymers for endosomal release (VIPER) to address systemic and intracellular delivery obstacles, but durable antitumor immunity remained elusive. Adjuvants stimulating innate immunity, such as stimulator of interferon genes (STING) agonists, can enhance vaccine potency but risks systemic toxicity and improper immune activation. We developed STING “drugamers” with cathepsin-cleavable linkers and dendritic cell (DC)-targeting moieties for intracellular delivery of STING agonists to DCs. We explored two different STING drugamer structures: a hydrophilic statistical polymer “polySTING” and a diblock polymer “NPSTING” that forms into nanoparticles. PolySTING achieved higher systemic STING agonist delivery, whereas NPSTING is more efficient in delivering STING agonists into inguinal lymph nodes (LNs). Both drugamer platforms enhanced STING activation and DC maturation compared to the free drug. When combined with VIPER, NPSTING generated more antigen-presenting DCs in the LNs and more antigen-responsive CD8 + T cells in the spleens, whereas polySTING generated more tumor-infiltrating CD8 + T cells and CD8 + DCs. Both VIPER–STING drugamer platforms demonstrated efficacy in a B16-OVA melanoma model and a MC38 colon cancer model. Combination treatment with anti-PD-1 immune checkpoint inhibitor results in tumor remission and tumor immunity in a subset of mice. This study highlights how an endosomolytic peptide vaccine platform combined with two structurally different drugamers induce superior antitumor responses through distinctive mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesMembrane ProteinsVaccines, SubunitAnimalsMiceDendritic CellsMice, Inbred C57BLFemaleCD8-Positive T-LymphocytesMelanoma, ExperimentalNanoparticlesCell Line, TumorHumansProtein Subunit VaccinesSTING Protein

Stichwörter der Autor:innen

STING agonistscancer immunotherapycancer peptide vaccinepolymeric delivery

Substanzen

Cancer VaccinesMembrane ProteinsVaccines, SubunitProtein Subunit VaccinesSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Department of Bioengineering, University of Washington, Seattle, WA 98195.
  • Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195.

ORCID-Profile: Kefan Song, Dinh Chuong Nguyen, Simbarashe Jokonya, Drew L Sellers, Suzie H Pun

Förderung

  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIAID NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • HHS | NIH | National Cancer Institute (NCI)

Zitieren

APA

Song, K., Nguyen, D. C., Wang, Y., Jokonya, S., Yazdani, O., Sellers, D. L., Stayton, P. S., & Pun, S. H. (2025). Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses. Proceedings of the National Academy of Sciences, 122(45). https://doi.org/10.1073/pnas.2409978122

Vancouver

Song K, Nguyen DC, Wang Y, Jokonya S, Yazdani O, Sellers DL, et al. Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses. Proceedings of the National Academy of Sciences. 2025;122(45). doi:10.1073/pnas.2409978122

BibTeX
@article{Song2025,
  author = {Song, Kefan and Nguyen, Dinh Chuong and Wang, Yonghui and Jokonya, Simbarashe and Yazdani, Omeed and Sellers, Drew L and Stayton, Patrick S and Pun, Suzie H},
  title = {Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {45},
  doi = {10.1073/pnas.2409978122}
}
Kostenlos starten →